Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2010; 16(46): 5830-5837
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830
Figure 3 GOT and GPT levels in sera of non-alcoholic fatty liver disease (A) or alcoholic fatty liver disease (B) patients carrying the Ala mutated allele or the Pro wild type allele of the peroxisome-proliferator-activated receptor-γ2 gene.
NAFLD: Non-alcoholic fatty liver disease; AFLD: Alcoholic fatty liver disease. Dots (●) indicate outliers that are not included between the whiskers.
- Citation: Rey JW, Noetel A, Hardt A, Canbay A, Alakus H, Hausen AZ, Dienes HP, Drebber U, Odenthal M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol 2010; 16(46): 5830-5837
- URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5830.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5830